Hyogen / Vaccines / Swine / Ceva United Kingdom

M.hyo: a real economical problem for pig farmers

Mycoplasma hyopneumoniae, associated with enzootic pneumonia, plays a major role in the porcine respiratory disease complex (PRDC) and can cause huge economic losses. A 17% decrease in daily weight gain and a 14% decrease in feed efficiency in herds with enzootic pneumonia has been reported1.

Mycoplasma hyopneumoniae is unable to penetrate and live within host cells but does colonise the mucosal surface of the ciliated epithelium of the respiratory system. In addition to the detrimental effect on the cilia, Mycoplasma hyopneumoniae infection attracts lymphocytes and macrophages into the lungs resulting in pneumonia. Protection against the infection requires complex activation of the host immune system.

Hyogen®: protect your pigs against Mycoplasma hyopneumoniae

After a single injection, Hyogen® provides effective protection against Mycoplasma hyopneumoniae due to the potent stimulation of the immune system by the antigen originated from Ceva Mycoplasma hyopneumoniae strain BA 2940-99 along with the adjuvant, Imuvant™.

Key features:

A single vaccination at 21 days of age provides early and long-lasting protection for up to 26 weeks
Contains the highly potent Ceva proprietary strain BA 2940-99
Imuvant™, a unique Ceva adjuvant
Expertise of the Ceva Lung Program

Hyogen® is supported in the field by the Ceva Lung Program. The Ceva Lung Program is a tool used in the slaughterhouse which provides an overview of the diseases associated with Actinobacillus pleuropeumoniae, Mycoplasma hyopneumoniae and Aujeszky’s disease virus. It offers the methodology and guidelines on how to correctly evaluate the presence, incidence, circulation patterns and impact of these infections using serological investigation and adapted lung scoring of slaughter pigs. It is used to determine the appropriate vaccination protocol and monitor the results of vaccination with Hyogen® and Coglapix®.

References:

Straw 1989

Hyogen emulsion for injection for pigs. Active ingredient: Hyogen® contains inactivated Mycoplasma hyopneumoniae 2940 strain. Please refer to the product packaging and leaflets for information about side effects, precautions and warnings. Legal Category: UK POM- V IE: POM. Further information is available on the SPC.